2L9
Blueprint Medicines Corp
Biopharmaceutical company developing precision therapies for genomically defined cancers, blood disorders, and inflammatory diseases
CUSIP: 09627Y109HealthcareUS1 holder
Recent Activity
2021Q2
2 sells
-2.71M shares
-2.71M shares
-213.1K shares
-213.1K shares
Loading more activity...